State of Wyoming’s AbCellera Biologics ABCL Stock Holding History

State of Wyoming’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+29,928	New	+$146K	0.02%	876
2023 Q3	–	Sell	-3,801	Closed	-$24.6K	–	1590
2023 Q2	$24.6K	Sell	3,801 -1,875	-33%	-$12.8K	0.01%	1398
2023 Q1	$42.8K	Sell	5,676 -7,230	-56%	-$65.7K	0.01%	1158
2022 Q4	$131K	Buy	12,906 +3,267	+34%	+$37.7K	0.04%	603
2022 Q3	$95K	Buy	9,639 +8,750	+984%	+$96K	0.05%	621
2022 Q2	$9K	Buy	889 +214	+32%	+$1.81K	0.01%	1647
2022 Q1	$7K	Buy	675 +114	+20%	+$1.08K	﹤0.01%	1635
2021 Q4	$8K	Sell	561 -30	-5%	-$455	﹤0.01%	1687
2021 Q3	$12K	Sell	591 -286	-33%	-$5.05K	0.01%	1000
2021 Q2	$19K	Buy	877 +404	+85%	+$11.1K	0.01%	926
2021 Q1	$16K	Buy	+473	New	+$18.8K	0.03%	341

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

State of Wyoming's ABCL Position: Q2 2026 in Review

State of Wyoming opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 29,928 shares worth $235K. The stake represents 0.02% of the portfolio and ranks #876 among its holdings. This is a return to the name: State of Wyoming previously reported a position in ABCL as recently as Q2 2023.

State of Wyoming first reported a position in ABCL in Q1 2021 and has held it in 11 quarters since. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

State of Wyoming held 29,928 shares of AbCellera Biologics worth $235K as of Q2 2026.
AbCellera Biologics was a new State of Wyoming position in Q2 2026.
AbCellera Biologics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #876 holding.
State of Wyoming first reported a position in AbCellera Biologics in Q1 2021 and has held it in 11 quarters since.
150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.